financetom
Business
financetom
/
Business
/
Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug
May 26, 2025 10:36 AM

May 19 (Reuters) - Pfizer ( PFE ) has signed a licensing

agreement worth up to $6 billion with Chinese pharmaceutical

products developer 3SBio Inc ( TRSBF ) for the development,

manufacturing and commercialization of a drug undergoing trials

for treatment of certain types of cancer and tumours, the U.S.

drugmaker said on Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Amerigo Resources Q1 Copper, Molybdenum Production Falls
Amerigo Resources Q1 Copper, Molybdenum Production Falls
Apr 9, 2025
08:25 AM EDT, 04/09/2025 (MT Newswires) -- Amerigo Resources ( ARREF ) said Wednesday its copper and molybdenum production fell in the first quarter. The company produced 13.23 million pounds of copper for the quarter ended March 31 at the Minera Valle Central (MVC) operation in Chile, down from 16 million pounds. Molybdenum production dropped to 240,000 pounds from 320,000...
Theratechnologies Swings to Q1 Profit as Sales Advance
Theratechnologies Swings to Q1 Profit as Sales Advance
Apr 9, 2025
08:24 AM EDT, 04/09/2025 (MT Newswires) -- Theratechnologies ( THTX ) on Wednesday said it swung to a first-quarter profit as revenue surged 17%. The company recorded a net profit of US$117,000, or nil per share, compared with a loss of US$4.5 million or US$0.10 per share, in the prior year period. Sales rose to US$19 million, boosted by a...
Eni expects investors to value Plenitude at more than $11 billion
Eni expects investors to value Plenitude at more than $11 billion
Apr 9, 2025
RAVENNA, Italy, April 9 (Reuters) - Eni expects investors interested in a minority stake in its renewables and retail arm, Plenitude, to value the business at more than 10 billion euros ($11 billion) including debt, one of the Italian energy group's executives said on Wednesday. Under its so-called satellite strategy, Eni plans to sell a second minority stake in Plenitude...
Copyright 2023-2026 - www.financetom.com All Rights Reserved